Dysregulation of miR-15a and miR-214 in human pancreatic cancer

Table 1 Expression of miRNAs in pancreatic cancer specimens compared with adjacent benign pancreatic tissues

miRNA	Median valve	Upregulated in pancreatic cancer reference (%)
miR-15a	0.56	(30%)
miR-27a	1.27	(50%)
miR-100	3.29	(70%)
miR-125b	3.16	(70%)
miR-181a	0.96	(50%)
miR-200a	2.78	(70%)
miR-214	2.78	(80%)

qRT-PCR was used to measure expression of seven miRNAs in 10 pancreatic cancer tissues and their adjacent benign pancreatic tissues. MiRNA expression levels are represented as relative values, compared to those of adjacent benign pancreatic tissues, which were taken as 1. Median value was calculated to indicate the frequency of a miRNA expression downregulated or upregulated in pancreatic cancer.

ISSN: 1756-8722